Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Compassionate Alternatives was an early-stage healthcare and medical cannabis organization primarily known for its role in the emerging medical marijuana market in Florida. The company was formed as a partnership to apply for dispensing organization licenses, focusing on the cultivation, processing, and distribution of low-THC cannabis for patients with terminal illnesses and chronic conditions. Its business model centered on providing therapeutic alternatives to traditional pharmaceuticals, particularly for palliative care and refractory epilepsy. Following the consolidation of the Florida cannabis market, the entity's assets and license applications were largely absorbed or superseded by larger multi-state operators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Compassionate Alternatives.